Physician profile
Benjamin Gates
NPI 1841502994
$4,542.45
in general payments reported to CMS, 2019-2025
15 companies · $721 in 2025
The $721 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,845 · 2020: $60.99 · 2021: $654 · 2022: $233 · 2023: $524 · 2024: $506 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,619 · Entertainment: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.91 |
| Entertainment | $131.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,494.35 | 2019-2021 | |
| Alcon Vision LLC | $750.49 | 2020-2025 | Precision7, Precision 1, Total30 |
| Optos, INC. | $646.04 | 2021-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $543.74 | 2022-2025 | Infuse |
| Johnson & Johnson Vision Care, INC. | $247.65 | 2019-2022 | |
| Biotissue Holdings INC. | $129.20 | 2023 | |
| Topcon Healthcare, INC. | $122.31 | 2025 | |
| Horizon Therapeutics Plc | $121.95 | 2022 | |
| Allergan, INC. | $110.77 | 2019-2021 | |
| Lkc Technologies, INC. | $109.73 | 2024 | |
| Sun Pharmaceutical Industries INC. | $89.42 | 2025 | |
| Maculogix, INC. | $76.35 | 2019 | |
| Coopervision INC. | $49.74 | 2019 | |
| Lombart Brothers, INC. | $28.17 | 2019 | |
| Zimvie INC. | $22.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Gates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.